023410 — EUGENE Income Statement

0.000.00%

Last trade - 00:00

Basic MaterialsConservativeSmall CapTurnaround

Market Cap
KR₩255bn
Enterprise Value
KR₩1tn
Revenue
KR₩1tn

Annual income statement for EUGENE, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,345,328	1,407,717	1,473,426	1,393,301	1,332,688
Cost of Revenue
Gross Profit	154,374	158,499	199,099	179,438	169,243
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	1,288,511	1,362,951	1,389,030	1,475,158	1,428,850
Operating Profit	56,817	44,767	84,396	-81,857	-96,162
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	106,276	-7,891	86,332	-85,827	-1,645
Provision for Income Taxes
Net Income After Taxes	78,373	-10,637	69,312	-100,746	-24,486
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	76,641	28,565	65,746	-57,685	-10,237
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	76,641	28,565	65,746	-57,685	-10,237
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	993	-116	939	456	975
Dividends per Share